Severe Generalized Weakness, Paralysis, and Aphasia following Administration of Irinotecan and Oxaliplatin during FOLFIRINOX Chemotherapy

BACKGROUND: Irinotecan is commonly used in combination with oxaliplatin as a component of FOLFIRINOX chemotherapy for several gastrointestinal malignancies. The purpose of this case report is to describe a patient who developed acute paralysis and aphasia while receiving her initial infusion of irin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandar, Manisha, de Wilton Marsh, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: March, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376921/
https://www.ncbi.nlm.nih.gov/pubmed/25873880
http://dx.doi.org/10.1159/000380849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376921/
https://www.ncbi.nlm.nih.gov/pubmed/25873880
http://dx.doi.org/10.1159/000380849

Ejemplares similares